Search research articles
Contact Us
Filters
Showing results (91-100 of 157) with videos related to
Page
of 16
Sort By:
British Journal of Cancer
|
May 5, 2005
Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours
A Awada, A Hendlisz, T Gil, et al.
Anales Espanoles De Pediatria
|
August 27, 1998
[Erythropoietin in anemia of the premature infant. Neonatal factors that are predictors of transfusion]
E Sastre Huerta, B Alonso Alvarez, R Montero Alonso, et al.
Anales De Medicina Interna (Madrid, Spain : 1984)
|
July 9, 2005
[Study on bacteremia in the service of Internal Medicine of a group 2 hospital. Analysis of recent three years]
A I Franco Moreno, S Casallo Blanco, F Marcos Sánchez, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia
|
November 23, 2006
[Functional dependency evaluation of hemodialysis patients: a multicentric study]
M D Arenas, F Alvarez-Ude, M Angoso, et al.
Clinical Nephrology
|
September 19, 2009
Nephrotic syndrome as paraneoplastic manifestation of a primary pulmonary lymphoepithelioma-like carcinoma
M D Arenas, M T Gil, T Malek, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia
|
April 5, 2011
[Dispositional optimism in patients on chronic haemodialysis and its possible influence on their clinical course]
A I Morales García, M D Arenas Jiménez, A Reig-Ferrer, et al.
Acta Clinica Belgica
|
July 25, 2014
Prospective non-interventional multicentre observational trial of first-line anti-cancer treatment in patients with metastatic renal cell cancer in Belgium
N Cornelis, T Vermassen, D Schallier, et al.
The New England Journal of Medicine
|
July 31, 1997
Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin
M Bolla, D Gonzalez, P Warde, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 20, 2009
Docetaxel plus oblimersen sodium (Bcl-2 antisense oligonucleotide): an EORTC multicenter, randomized phase II study in patients with castration-resistant prostate cancer
C N Sternberg, H Dumez, H Van Poppel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 10, 2013
An open-label, phase 2 study evaluating the efficacy and safety of the anti-IGF-1R antibody cixutumumab in patients with previously treated advanced or metastatic soft-tissue sarcoma or Ewing family of tumours
P Schöffski, D Adkins, J-Y Blay, et al.
Page
of 16
Search research articles
Search
Showing results (91-100 of 157) with videos related to
Sort By:
Page
of 16
British Journal of Cancer
|
May 5, 2005
Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours
A Awada, A Hendlisz, T Gil, et al.
Anales Espanoles De Pediatria
|
August 27, 1998
[Erythropoietin in anemia of the premature infant. Neonatal factors that are predictors of transfusion]
E Sastre Huerta, B Alonso Alvarez, R Montero Alonso, et al.
Anales De Medicina Interna (Madrid, Spain : 1984)
|
July 9, 2005
[Study on bacteremia in the service of Internal Medicine of a group 2 hospital. Analysis of recent three years]
A I Franco Moreno, S Casallo Blanco, F Marcos Sánchez, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia
|
November 23, 2006
[Functional dependency evaluation of hemodialysis patients: a multicentric study]
M D Arenas, F Alvarez-Ude, M Angoso, et al.
Clinical Nephrology
|
September 19, 2009
Nephrotic syndrome as paraneoplastic manifestation of a primary pulmonary lymphoepithelioma-like carcinoma
M D Arenas, M T Gil, T Malek, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia
|
April 5, 2011
[Dispositional optimism in patients on chronic haemodialysis and its possible influence on their clinical course]
A I Morales García, M D Arenas Jiménez, A Reig-Ferrer, et al.
Acta Clinica Belgica
|
July 25, 2014
Prospective non-interventional multicentre observational trial of first-line anti-cancer treatment in patients with metastatic renal cell cancer in Belgium
N Cornelis, T Vermassen, D Schallier, et al.
The New England Journal of Medicine
|
July 31, 1997
Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin
M Bolla, D Gonzalez, P Warde, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 20, 2009
Docetaxel plus oblimersen sodium (Bcl-2 antisense oligonucleotide): an EORTC multicenter, randomized phase II study in patients with castration-resistant prostate cancer
C N Sternberg, H Dumez, H Van Poppel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 10, 2013
An open-label, phase 2 study evaluating the efficacy and safety of the anti-IGF-1R antibody cixutumumab in patients with previously treated advanced or metastatic soft-tissue sarcoma or Ewing family of tumours
P Schöffski, D Adkins, J-Y Blay, et al.
Page
of 16